Lifecore Biomedical, Inc. \De\ (LFCR) Long-Term Deferred Tax (2016 - 2018)
Historic Long-Term Deferred Tax for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 4 years, with Q2 2018 value amounting to $17.5 million.
- Lifecore Biomedical, Inc. \De\'s Long-Term Deferred Tax fell 2886.78% to $17.5 million in Q2 2018 from the same period last year, while for May 2018 it was $17.5 million, marking a year-over-year decrease of 2886.78%. This contributed to the annual value of $17.5 million for FY2018, which is 2886.78% down from last year.
- Per Lifecore Biomedical, Inc. \De\'s latest filing, its Long-Term Deferred Tax stood at $17.5 million for Q2 2018, which was down 2886.78% from $24.6 million recorded in Q2 2017.
- Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Long-Term Deferred Tax peaked at $32.2 million during Q2 2015, and registered a low of $17.5 million during Q2 2018.
- For the 4-year period, Lifecore Biomedical, Inc. \De\'s Long-Term Deferred Tax averaged around $24.2 million, with its median value being $23.5 million (2016).
- As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Long-Term Deferred Tax crashed by 3036.71% in 2016, and later soared by 953.12% in 2017.
- Lifecore Biomedical, Inc. \De\'s Long-Term Deferred Tax (Quarter) stood at $32.2 million in 2015, then plummeted by 30.37% to $22.4 million in 2016, then grew by 9.53% to $24.6 million in 2017, then fell by 28.87% to $17.5 million in 2018.
- Its Long-Term Deferred Tax was $17.5 million in Q2 2018, compared to $24.6 million in Q2 2017 and $22.4 million in Q2 2016.